Dr. James O’Byrne

Our Retina International World Congress (RIWC24) takes place from the 5th – 8th June 2024 in the Dublin Royal Convention Centre, in the heart of Dublin city centre.

Our Scientific Committee has been working relentlessly to secure an impressive lineup of outstanding speakers to shed light on this research area so as part of our Meet the Speaker series, we are delighted to announce one more distinguished speaker.

Dr James O’Byrne is a consultant Metabolic Physician and Consultant Clinical Geneticist based in the Adult Metabolic Unit at the Mater Misericordiae University Hospital (MMUH) and Associative Clinical Professor in the School of Medicine, University College Dublin.

We are delighted to have Dr James O’Byrne with us at the Retina International World Congress chairing the Afternoon Parallel Session on IRDs on Saturday, June 8, 2:00 PM – 3:45 PM, located at Douglas Hyde.

Image description: Headshot of Dr. James O'Byrne on a blue background image. Text: Retina International World Congress. Dublin Royal Convention Centre, Dublin, Ireland. RIWC24. DUBLIN: Targeting the Cure. JUNE 5-8, 2024. DR. JAMES O'BYRNE, Consultant Metabolic Physician and Consultant Clinical Geneticist, Mater Misericordiae University Hospital (MMUH), Associative Clinical Professor in the School of Medicine, University College Dublin (UCD)). At the bottom of the image, there are the Fighting Blindness and Retina International logos.

Dr O’Byrne’s special interests include the organelle diseases; Lysosomal Storage and Peroxisomal Disorders and the development and application of gene specific treatments or precision medicine within this field. He is the Principal Investigator in Ireland on a phase 3 clinical trial for a novel therapy for Fabry Disease. He holds a PhD from the Karolinska Institute, Stockholm in Peroxisomal Disorders and Fatty Acid/ Bile Acid Metabolism and completed a fellowship at British Columbia Children’s Hospital and Vancouver General Hospital, working with patients with treatable genetic disorders that result in intellectual disability. Working as a Consultant Clinical Geneticist  Dr O’Byrne also supports the development of a number of genetic initiatives across a number of specialties including ophthalmology, cardiology, neurology and oncology at the Mater Hospital. Dr O’Byrne graduated from Medical School in Trinity College Dublin (TCD), attained Certificate of Satisfactory Completion of Specialist Training in Clinical/Biochemical Genetics from the Royal College of Physicians of Ireland (RCPI) and holds a membership examination in paediatrics from RCPI and a basic science degree in Biochemistry from TCD.  Dr O’Byrne is a council member of the Irish Society of Human Genetics and European Society of Human Genetics Education Committee. He has a deep interest in education, lectures in the fields of Metabolic Medicine, Clinical Genetics/Genomics and Rare Diseases and is director of the new ESHG course entitled Precision Medicine: A Focus on Clinical Utility due to start in 2022.

Stay tuned for more updates as we draw closer to this incredible gathering of the latest scientific research and innovation, set to take place in June 2024!

For registrations please click here.